Bayer AG (OTC Pink - Current Information:BAYRY)
| 16.26 Delayed Data As of Jun 11 |  +0.05 / +0.31%Today’s Change | 11.65 Today|||52-Week Range 21.05 | +9.57% Year-to-Date |
Latest BAYRY News | Press Releases
| Pfizer (PFE) Gets FDA Nod for Pneumococcal Vaccine Prevnar 20 Jun 09 / Zacks.com - Paid Partner Content | Novo Nordisk (NVO) Inks Deal to Develop Heart Failure Treatment Jun 01 / Zacks.com - Paid Partner Content |
| Novartis (NVS) Posts Positive Data on Kidney Disease Candidate Jun 07 / Zacks.com - Paid Partner Content | Sanofi (SNY) Stops Venglustat Development as Kidney Cyst Drug Jun 01 / Zacks.com - Paid Partner Content |
| J&J (JNJ) to Pay $2.5B in Baby Powder Case on Appeal Rejection Jun 02 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 16.21 |
| Today’s open | 16.25 |
| Day’s range | 16.20 - 16.28 |
| Volume | 196,624 |
| Average volume (3 months) | 411,503 |
| Market cap | $63.9B |
Data as of 06/11/2021
Growth & Valuation
| Earnings growth (last year) | -361.08% |
| Earnings growth (this year) | -8.12% |
| Earnings growth (next 5 years) | +1.67% |
| Revenue growth (last year) | -3.17% |
| P/E ratio | -- |
| Price/Sales | 1.23 |
| Price/Book | 1.71 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 5, 2021 |
| EPS forecast (this quarter) | $0.45 |
| Annual revenue (last year) | $47.2B |
| Annual profit (last year) | -$12.0B |
| Net profit margin | -37.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Leverkusen, Nordrhein-westfalen |
Forecasts
Chart unavailable
